ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05321	Inflammatory bowel disease (IBD)	1/2	56/7206	0.0154832804725
ko05140	Leishmaniasis	1/2	75/7206	0.0207090898693
ko05130	Pathogenic Escherichia coli infection	1/2	77/7206	0.0212583661201
ko05212	Pancreatic cancer	1/2	83/7206	0.0229052703599
ko04917	Prolactin signaling pathway	1/2	87/7206	0.0240024360918
ko04658	Th1 and Th2 cell differentiation	1/2	96/7206	0.026468805489
ko04620	Toll-like receptor signaling pathway	1/2	100/7206	0.0275639681099
ko04659	Th17 cell differentiation	1/2	106/7206	0.0292055564002
ko05162	Measles	1/2	120/7206	0.033030536085
ko05145	Toxoplasmosis	1/2	126/7206	0.0346675018105
ko04630	Jak-STAT signaling pathway	1/2	132/7206	0.0363030807665
ko04380	Osteoclast differentiation	1/2	134/7206	0.0368479655809
ko04933	AGE-RAGE signaling pathway in diabetic complications	1/2	135/7206	0.0371203502055
ko04919	Thyroid hormone signaling pathway	1/2	143/7206	0.0392980404373
ko05160	Hepatitis C	1/2	153/7206	0.0420166863035
ko04621	NOD-like receptor signaling pathway	1/2	157/7206	0.0431030660512
ko05164	Influenza A	1/2	167/7206	0.0458163189254
ko05161	Hepatitis B	1/2	173/7206	0.0474424216231
ko05418	Fluid shear stress and atherosclerosis	1/2	173/7206	0.0474424216231
ko04217	Necroptosis	1/2	178/7206	0.048796447868
ko05168	Herpes simplex infection	1/2	182/7206	0.0498789754781